Elysse Bautista-González
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Elysse Bautista-González has a total of 127 co-authors. Here are the top co-authors by number of shared publications:
- Cecilia Vindrola-Padros
Rapid Research Evaluation and Appraisal Lab (RREAL), Department of Targeted Intervention, University College London, London, WC1E 6BT, UK
11 shared publications - Anne Peasey
Institute of Epidemiology and Health Care, University College London, London, UK
6 shared publications - Hynek Pikhart
Institute of Epidemiology and Health Care, University College London, London, UK
5 shared publications Cecilia Vindrola-Padros
Rapid Research Evaluation and Appraisal Lab, University College London, London, UK
4 shared publicationsAndrés Quintero-Leyra
School of Medicine UNAM Mexico City Mexico
3 shared publications- Aron Syversen
School of Computer Science, University of Leeds, Leeds, UK
3 shared publications
Latest Publications
- Open Access
- 17 November 2026
- Published by Instituto Mexicano del Seguro Social in Mexican Journal of Oncology
- Vol. 22 (4)
Code Cancer: preliminary results
Background: Delays in medical intervention for people living with cancer negatively impact the quality of life and increase costs to the healthcare system. Objective: To describe the "Code Cancer" project phases and their preliminary results. Methods: Seven research groups organized to: a) understand the causes of delays faced by people with cancer in Mexico, their trajectories, and associated costs; b) understand the formal and informal referral mechanisms that constitute their trajectory in the health system, and c) understand the existing and necessary infrastructure to respond to the epidemiological needs of the country. Results: These preliminary results lay the groundwork for implementing a rapid patient referral program. Conclusions: Evidence-based policies for early cancer diagnosis and treatment are essential to address delays in medical assistance. "Code Cancer" represents an innovative project to achieve this goal in Mexico.
- 17 November 2026
- Published by Instituto Mexicano del Seguro Social in Mexican Journal of Oncology
- Vol. 22 (4)
Open AccessCode Cancer: preliminary results
Background: Delays in medical intervention for people living with cancer negatively impact the quality of life and increase costs to the healthcare system. Objective: To describe the "Code Cancer" project phases and their preliminary results. Methods: Seven research groups organized to: a) understand the causes of delays faced by people with cancer in Mexico, their trajectories, and associated costs; b) understand the formal and informal referral mechanisms that constitute their trajectory in the health system, and c) understand the existing and necessary infrastructure to respond to the epidemiological needs of the country. Results: These preliminary results lay the groundwork for implementing a rapid patient referral program. Conclusions: Evidence-based policies for early cancer diagnosis and treatment are essential to address delays in medical assistance. "Code Cancer" represents an innovative project to achieve this goal in Mexico.
- Open Access
- 2 September 2026
- Published by Springer Nature in BMC Cancer
Aligning patient navigation activities with the early cancer care agenda in LMICs: a framework for implementation across the cancer continuum
- 2 September 2026
- Published by Springer Nature in BMC Cancer
Open AccessAligning patient navigation activities with the early cancer care agenda in LMICs: a framework for implementation across the cancer continuum
- Open Access
- 27 May 2026
- Published by Springer Nature in BMC Global and Public Health
- Vol. 4 (1) , 50
Lung cancer care pathways and journeys: insights from patients at the National Cancer Institute in Mexico
Background: Delayed diagnosis and treatment remain major contributors to poor lung cancer outcomes in Mexico, where fragmented service delivery and weak referral coordination shape patient trajectories. Integrating patient narratives with measurable time intervals is critical to understanding how health system structures translate into lived delays and inequities. Methods: We conducted a convergent mixed-methods study using routinely collected electronic health record data and structured patient interviews at the National Cancer Institute of Mexico (INCAN). Relevant dates were extracted for all suspected lung cancer patients admitted between 2004 and 2021 ( N = 2,645). Descriptive statistics, interval calculations, pathway classification, and temporal trends were drawn. In parallel, a purposive subsample of patients ( N = 46) participated in structured interviews exploring symptom appraisal, help-seeking, travel, and interactions with health services. Quantitative and qualitative data were collected concurrently and analysed independently with equal priority. Open-ended interview data were analysed thematically, and structured electronic health record data were quantified. Integration then occurred through joint displays combining interview-derived data with medical record variables to link measured delays and clinical pathways with patients’ contextual characteristics and reconstruct individual care journeys. Results: Four diagnostic pathways were identified, reflecting where and how diagnosis occurred in N = 2645 patients. Median time from first symptom to treatment ranged from 160 to 255 days, with substantial variation by pathway and year of admission. Interviews revealed N = 41 patients were symptomatic at the time of first appraisal. Recurrent patterns of delayed self-appraisal ( N = 61 (median days to first encounter after first symptom), misdiagnosis ( N = 24), fragmented referrals, financial insecurity, and long-distance travel to access specialised care. Patients commonly navigated multiple public and private providers before reaching INCAN with very few arriving solely from a public pathway, reaching a median of 3 medical encounters before diagnosis, and thus often incurring out-of-pocket costs and experiencing interruptions in care. Conclusions: Stratifying lung cancer outcomes by diagnostic pathway and linking interval-based metrics to patient experience reveals how health system fragmentation generates avoidable delays and inequities. Policy responses should prioritise coordinated referral pathways, strengthened regional diagnostic capacity, financial protection mechanisms, and early detection competencies across levels of care.
- 27 May 2026
- Published by Springer Nature in BMC Global and Public Health
- Vol. 4 (1) , 50
Open AccessLung cancer care pathways and journeys: insights from patients at the National Cancer Institute in Mexico
Background: Delayed diagnosis and treatment remain major contributors to poor lung cancer outcomes in Mexico, where fragmented service delivery and weak referral coordination shape patient trajectories. Integrating patient narratives with measurable time intervals is critical to understanding how health system structures translate into lived delays and inequities. Methods: We conducted a convergent mixed-methods study using routinely collected electronic health record data and structured patient interviews at the National Cancer Institute of Mexico (INCAN). Relevant dates were extracted for all suspected lung cancer patients admitted between 2004 and 2021 ( N = 2,645). Descriptive statistics, interval calculations, pathway classification, and temporal trends were drawn. In parallel, a purposive subsample of patients ( N = 46) participated in structured interviews exploring symptom appraisal, help-seeking, travel, and interactions with health services. Quantitative and qualitative data were collected concurrently and analysed independently with equal priority. Open-ended interview data were analysed thematically, and structured electronic health record data were quantified. Integration then occurred through joint displays combining interview-derived data with medical record variables to link measured delays and clinical pathways with patients’ contextual characteristics and reconstruct individual care journeys. Results: Four diagnostic pathways were identified, reflecting where and how diagnosis occurred in N = 2645 patients. Median time from first symptom to treatment ranged from 160 to 255 days, with substantial variation by pathway and year of admission. Interviews revealed N = 41 patients were symptomatic at the time of first appraisal. Recurrent patterns of delayed self-appraisal ( N = 61 (median days to first encounter after first symptom), misdiagnosis ( N = 24), fragmented referrals, financial insecurity, and long-distance travel to access specialised care. Patients commonly navigated multiple public and private providers before reaching INCAN with very few arriving solely from a public pathway, reaching a median of 3 medical encounters before diagnosis, and thus often incurring out-of-pocket costs and experiencing interruptions in care. Conclusions: Stratifying lung cancer outcomes by diagnostic pathway and linking interval-based metrics to patient experience reveals how health system fragmentation generates avoidable delays and inequities. Policy responses should prioritise coordinated referral pathways, strengthened regional diagnostic capacity, financial protection mechanisms, and early detection competencies across levels of care.
- Open Access
- 16 April 2026
- Published by Oxford University Press (OUP) in The Oncologist
- Vol. 31 (5)
Health system strengthening recommendations for Lung Cancer Care: Lessons from the COVID-19 Pandemic
We explore how the COVID-19 pandemic amplified barriers across the lung cancer care continuum in Mexico. Drawing from a cross-sectional qualitative arm of a mixed methods study (N = 46), interviews were conducted with lung cancer patients at the Mexican National Cancer Institute between 2020–2021. Using thematic analysis, patients reported care delays due to fear of infection, unclear communication, and service disruptions. Thematic patterns revealed that these challenges were compounded by financial hardship, emotional distress, and reluctance to seek care. Key policy and practice implications include the need for flexible healthcare delivery models, improved communication strategies, financial support mechanisms, tailored interventions for care-seeking behaviours, and integrated mental health and community support. These findings underscore the urgency for systemic adaptations to safeguard timely cancer care during future health crises, particularly in middle-income settings like Mexico. Ethical approval was obtained from the Mexican National Cancer Institute. Lung cancer patients participated in structured interviews on symptom recognition, healthcare-seeking behaviour, and the impact of the COVID-19 pandemic. Interviews were analysed thematically using Braun and Clarke’s framework. The following themes arose:
- 16 April 2026
- Published by Oxford University Press (OUP) in The Oncologist
- Vol. 31 (5)
Open AccessHealth system strengthening recommendations for Lung Cancer Care: Lessons from the COVID-19 Pandemic
We explore how the COVID-19 pandemic amplified barriers across the lung cancer care continuum in Mexico. Drawing from a cross-sectional qualitative arm of a mixed methods study (N = 46), interviews were conducted with lung cancer patients at the Mexican National Cancer Institute between 2020–2021. Using thematic analysis, patients reported care delays due to fear of infection, unclear communication, and service disruptions. Thematic patterns revealed that these challenges were compounded by financial hardship, emotional distress, and reluctance to seek care. Key policy and practice implications include the need for flexible healthcare delivery models, improved communication strategies, financial support mechanisms, tailored interventions for care-seeking behaviours, and integrated mental health and community support. These findings underscore the urgency for systemic adaptations to safeguard timely cancer care during future health crises, particularly in middle-income settings like Mexico. Ethical approval was obtained from the Mexican National Cancer Institute. Lung cancer patients participated in structured interviews on symptom recognition, healthcare-seeking behaviour, and the impact of the COVID-19 pandemic. Interviews were analysed thematically using Braun and Clarke’s framework. The following themes arose:
- Open Access
- 10 April 2026
- Published by MDPI AG in Current Oncology
- Vol. 33 (4) , 211
Mixed-Methods Evaluation of the Delivery of Cancer Care to Teenagers and Young Adults in England and Wales: BRIGHTLIGHT_2021
Background: Healthcare policy in the United Kingdom recognizes that teenagers and young adults (TYAs: 16–24 years at diagnosis) require specialist care. In England, Principal Treatment Centers (PTCs) exist, delivering enhanced care exclusively within the PTC or as ‘joint care’ with designated hospitals (DHs). Central to this is the TYA multidisciplinary team (MDT) and an outreach model coordinating care between hospitals. We previously reported similar outcomes regardless of care location. Aims: To compare TYA experiences of care with healthcare professionals’ perspectives of the service they deliver. Methods: Mixed methods across England and Wales were used. The TYA-MDT identified TYAs who then received a postal invite to a cross-sectional survey capturing experiences of places of care, treatment, healthcare professional support (HCP), mental health, sexuality/fertility, clinical trials and care coordination. Comparisons were made based on exposure to care in a specialist TYA environment within 6 months of diagnosis: all-TYA-PTC (all care in the TYA-PTC, n = 70, 28%), no-TYA-PTC (no care in the TYA-PTC (n = 87, 35%): care delivered in a children/adult unit only), and joint care (care in a TYA-PTC and in a children’s/adult unit, n = 91, 36%). HCP perspectives were captured by rapid ethnography. Results: A total of 250/1056 (24%) TYAs participated. Overall, 200 (80%) rated their teams as excellent/good for helping them prepare for treatment. No evidence of significant differences existed between categories of care for proportions receiving support from key TYA-related professionals: TYA cancer nurse specialists (all-TYA-PTC n = 58, 91%; joint care n = 71, 88%; no-TYA-PTC n = 64, 82%) and social workers (all-TYA-PTC n = 30, 55%; joint care n = 36, 48%; no-TYA-PTC n = 28, 38%). A trend of diminishing support from youth support co-coordinators existed (all-TYA-PTC 63%; joint care 49%; no-TYA-PTC 40%, p = 0.069). This may explain why few differences in patient experiences existed across categories of care. Forty-nine HCPs participated. They were more critical in their interpretation of care, highlighting inequity in resources and challenges in some pathways and coordination. Conclusions: Similar access to age-appropriate support across care settings is likely to reflect recruitment methods. When TYAs are known to the MDT, age-appropriate care can be mobilized beyond TYA units, which could explain the equitable outcomes observed across different care locations in young people who responded to the survey. Nevertheless, gaps persist in communication and coordination, particularly within joint care models, and in the involvement of allied health professionals such as dieticians and physiotherapists, whose input is essential for rehabilitation and return to normal life. Strengthening these areas will require continued investment in workforce capacity and digital infrastructure to support genuinely coordinated, developmentally appropriate TYA cancer care.
- 10 April 2026
- Published by MDPI AG in Current Oncology
- Vol. 33 (4) , 211
Open AccessMixed-Methods Evaluation of the Delivery of Cancer Care to Teenagers and Young Adults in England and Wales: BRIGHTLIGHT_2021
Background: Healthcare policy in the United Kingdom recognizes that teenagers and young adults (TYAs: 16–24 years at diagnosis) require specialist care. In England, Principal Treatment Centers (PTCs) exist, delivering enhanced care exclusively within the PTC or as ‘joint care’ with designated hospitals (DHs). Central to this is the TYA multidisciplinary team (MDT) and an outreach model coordinating care between hospitals. We previously reported similar outcomes regardless of care location. Aims: To compare TYA experiences of care with healthcare professionals’ perspectives of the service they deliver. Methods: Mixed methods across England and Wales were used. The TYA-MDT identified TYAs who then received a postal invite to a cross-sectional survey capturing experiences of places of care, treatment, healthcare professional support (HCP), mental health, sexuality/fertility, clinical trials and care coordination. Comparisons were made based on exposure to care in a specialist TYA environment within 6 months of diagnosis: all-TYA-PTC (all care in the TYA-PTC, n = 70, 28%), no-TYA-PTC (no care in the TYA-PTC (n = 87, 35%): care delivered in a children/adult unit only), and joint care (care in a TYA-PTC and in a children’s/adult unit, n = 91, 36%). HCP perspectives were captured by rapid ethnography. Results: A total of 250/1056 (24%) TYAs participated. Overall, 200 (80%) rated their teams as excellent/good for helping them prepare for treatment. No evidence of significant differences existed between categories of care for proportions receiving support from key TYA-related professionals: TYA cancer nurse specialists (all-TYA-PTC n = 58, 91%; joint care n = 71, 88%; no-TYA-PTC n = 64, 82%) and social workers (all-TYA-PTC n = 30, 55%; joint care n = 36, 48%; no-TYA-PTC n = 28, 38%). A trend of diminishing support from youth support co-coordinators existed (all-TYA-PTC 63%; joint care 49%; no-TYA-PTC 40%, p = 0.069). This may explain why few differences in patient experiences existed across categories of care. Forty-nine HCPs participated. They were more critical in their interpretation of care, highlighting inequity in resources and challenges in some pathways and coordination. Conclusions: Similar access to age-appropriate support across care settings is likely to reflect recruitment methods. When TYAs are known to the MDT, age-appropriate care can be mobilized beyond TYA units, which could explain the equitable outcomes observed across different care locations in young people who responded to the survey. Nevertheless, gaps persist in communication and coordination, particularly within joint care models, and in the involvement of allied health professionals such as dieticians and physiotherapists, whose input is essential for rehabilitation and return to normal life. Strengthening these areas will require continued investment in workforce capacity and digital infrastructure to support genuinely coordinated, developmentally appropriate TYA cancer care.
- Open Access
Exploring the Coordination of Cancer Care for Teenagers and Young Adults in England and Wales: BRIGHTLIGHT_2021 Rapid Qualitative Study
Background: Commissioning of ‘joint care’ across teenage and young adult (TYA) principal treatment centres (PTC) and regional designated hospitals was introduced to enable cancer care closer to home, while providing support through the TYA multidisciplinary team. We aimed to explore the processes being used to enable inter-organisational collaboration under joint care models through rapid ethnography. Methods: Healthcare professionals in TYA PTCs in England and Wales between June 2022 and December 2023 were identified by the TYA lead in each PTC as delivering TYA cancer care. Semi-structured interviews were conducted virtually or by telephone based on the structuration model of collaboration proposed by D’Amour. Data were analysed against the model through framework analysis. Results: Our study highlighted variation across the different dimensions of inter-organisational collaboration. We found that healthcare professionals delivering TYA cancer care were working toward a shared goal but this was not always achieved. Social interaction between professionals was required to develop relationships and trust, but opportunities for social interaction were not regularly available. Processes for sharing information were not streamlined, so there were instances when information could not be shared between organisations. Interventions to achieve coordinated care, such as an outreach team, supported the delivery of joint care but these were not available in every region. While there were some levels of leadership within aspects of services, there were limited examples nationally or across geographical regions, which hindered the development of coordinated care. Conclusions: Coordination of care is mostly developing; however, the shared vision and goals dimension did achieve full active collaboration. The implementation of a service specification will address regional leadership requirements, but resources are required to extend the delivery of interventions to support coordination and collaboration, allowing the commissioned model of care to be delivered safely.
Open AccessExploring the Coordination of Cancer Care for Teenagers and Young Adults in England and Wales: BRIGHTLIGHT_2021 Rapid Qualitative Study
Background: Commissioning of ‘joint care’ across teenage and young adult (TYA) principal treatment centres (PTC) and regional designated hospitals was introduced to enable cancer care closer to home, while providing support through the TYA multidisciplinary team. We aimed to explore the processes being used to enable inter-organisational collaboration under joint care models through rapid ethnography. Methods: Healthcare professionals in TYA PTCs in England and Wales between June 2022 and December 2023 were identified by the TYA lead in each PTC as delivering TYA cancer care. Semi-structured interviews were conducted virtually or by telephone based on the structuration model of collaboration proposed by D’Amour. Data were analysed against the model through framework analysis. Results: Our study highlighted variation across the different dimensions of inter-organisational collaboration. We found that healthcare professionals delivering TYA cancer care were working toward a shared goal but this was not always achieved. Social interaction between professionals was required to develop relationships and trust, but opportunities for social interaction were not regularly available. Processes for sharing information were not streamlined, so there were instances when information could not be shared between organisations. Interventions to achieve coordinated care, such as an outreach team, supported the delivery of joint care but these were not available in every region. While there were some levels of leadership within aspects of services, there were limited examples nationally or across geographical regions, which hindered the development of coordinated care. Conclusions: Coordination of care is mostly developing; however, the shared vision and goals dimension did achieve full active collaboration. The implementation of a service specification will address regional leadership requirements, but resources are required to extend the delivery of interventions to support coordination and collaboration, allowing the commissioned model of care to be delivered safely.
- Open Access
Does Joint Care Impact Teenage and Young Adult’s Patient-Reported Outcomes After a Cancer Diagnosis? Results from BRIGHTLIGHT_2021
Background: Healthcare policy in the United Kingdom recognizes that teenagers and young adults (TYA:16–24 years at diagnosis) require specialist care. In England, Principal Treatment Centers (PTCs) exist, delivering enhanced care exclusively within the PTC or as ‘joint care’ with designated hospitals (DHs). We examined whether joint care impacted patient-reported outcomes when compared to care at one site. Methods: A cross-sectional survey was conducted in England, Scotland, and Wales. This included validated measures of quality of life (QoL), anxiety and depression, health status, social support, and illness perception. Comparisons were made based on young people’s exposure to specialist care within 6 months of diagnosis, defined as care in a TYA PTC: all-TYA-care (all care in a TYA unit), no-TYA-care (no care in a TYA unit, care delivered in a children’s/adult unit only), and joint-care (care in a TYA-PTC and in a children’s/adult unit). Results: Overall, 260/1009 (25.8%) participants responded (England n = 241; Scotland/Wales n = 19). Due to different healthcare policies, statistical analysis was applied to England only. Mean QoL scores were <69.7, the threshold indicating impaired QoL (mean 58.65, standard deviation 20.13). After adjustment for confounding factors, no clinically significant differences in mean QoL between categories existed. The adjusted mean difference for all-TYA-care (n = 66) versus no-TYA-care (n = 89) was −2.28 units (95% confidence interval (CI: −8.85 to 4.29) and for joint-care versus no-TYA-care (n = 85), −4.35 units (CI: −10.34 to 1.63). Similarly, no notable differences in social support, anxiety, depression, or illness perception between categories existed. Patients receiving all-TYA-care had a lower average health status compared with no-TYA-care (difference in means −0.09 (CI:−0.18 to −0.01). Conclusions: No evidence that patient-reported outcomes differ by categories of care existed. This may suggest the evolution of TYA cancer services has led to similar outcomes regardless of care category. However, given the small sample size it is not possible to draw firm conclusions.
Open AccessDoes Joint Care Impact Teenage and Young Adult’s Patient-Reported Outcomes After a Cancer Diagnosis? Results from BRIGHTLIGHT_2021
Background: Healthcare policy in the United Kingdom recognizes that teenagers and young adults (TYA:16–24 years at diagnosis) require specialist care. In England, Principal Treatment Centers (PTCs) exist, delivering enhanced care exclusively within the PTC or as ‘joint care’ with designated hospitals (DHs). We examined whether joint care impacted patient-reported outcomes when compared to care at one site. Methods: A cross-sectional survey was conducted in England, Scotland, and Wales. This included validated measures of quality of life (QoL), anxiety and depression, health status, social support, and illness perception. Comparisons were made based on young people’s exposure to specialist care within 6 months of diagnosis, defined as care in a TYA PTC: all-TYA-care (all care in a TYA unit), no-TYA-care (no care in a TYA unit, care delivered in a children’s/adult unit only), and joint-care (care in a TYA-PTC and in a children’s/adult unit). Results: Overall, 260/1009 (25.8%) participants responded (England n = 241; Scotland/Wales n = 19). Due to different healthcare policies, statistical analysis was applied to England only. Mean QoL scores were <69.7, the threshold indicating impaired QoL (mean 58.65, standard deviation 20.13). After adjustment for confounding factors, no clinically significant differences in mean QoL between categories existed. The adjusted mean difference for all-TYA-care (n = 66) versus no-TYA-care (n = 89) was −2.28 units (95% confidence interval (CI: −8.85 to 4.29) and for joint-care versus no-TYA-care (n = 85), −4.35 units (CI: −10.34 to 1.63). Similarly, no notable differences in social support, anxiety, depression, or illness perception between categories existed. Patients receiving all-TYA-care had a lower average health status compared with no-TYA-care (difference in means −0.09 (CI:−0.18 to −0.01). Conclusions: No evidence that patient-reported outcomes differ by categories of care existed. This may suggest the evolution of TYA cancer services has led to similar outcomes regardless of care category. However, given the small sample size it is not possible to draw firm conclusions.
- Open Access
- 26 November 2025
- Published by Springer Nature in Archives of Public Health
- Vol. 83 (1)
Patient navigation programmes for symptomatic lung cancer patients: a scoping review
Introduction: This scoping review investigates the landscape of patient navigation programs (PNP) specifically for lung cancer, addressing a gap in existing literature that has predominantly focused on other cancers or chronic diseases and screening. Methods: Employing Arksey and O’Malley’s framework and PRISMA-ScR guidelines, we aimed to characterize the features of lung cancer PNP, understand their outcomes, and analyse the applied methodologies for research. The search was conducted in January 2025. Results: The search led to the inclusion of 16 studies, predominantly from high-income countries, revealing a variety of implementation strategies and navigator types. Findings indicate a significant emphasis on administrative outcomes, clinical and patient-reported outcomes with heterogeneity in its use. Emotional support, logistical assistance, and healthcare system navigation emerged as key themes in service delivery, however PNP focus is inconsistent. The analysis highlighted the need for standardized methodologies and outcome measures, as well as greater inclusivity in research populations. Importantly, the review identified a trend of excluding marginalized demographics, raising concerns about the generalizability and external validity of findings. Conclusion: Our study underscores the necessity for future research to harmonize PNP methodologies, enhance transparency in collaborative efforts, and focus on addressing health inequalities to optimize the effectiveness of lung cancer navigation initiatives.
- 26 November 2025
- Published by Springer Nature in Archives of Public Health
- Vol. 83 (1)
Open AccessPatient navigation programmes for symptomatic lung cancer patients: a scoping review
Introduction: This scoping review investigates the landscape of patient navigation programs (PNP) specifically for lung cancer, addressing a gap in existing literature that has predominantly focused on other cancers or chronic diseases and screening. Methods: Employing Arksey and O’Malley’s framework and PRISMA-ScR guidelines, we aimed to characterize the features of lung cancer PNP, understand their outcomes, and analyse the applied methodologies for research. The search was conducted in January 2025. Results: The search led to the inclusion of 16 studies, predominantly from high-income countries, revealing a variety of implementation strategies and navigator types. Findings indicate a significant emphasis on administrative outcomes, clinical and patient-reported outcomes with heterogeneity in its use. Emotional support, logistical assistance, and healthcare system navigation emerged as key themes in service delivery, however PNP focus is inconsistent. The analysis highlighted the need for standardized methodologies and outcome measures, as well as greater inclusivity in research populations. Importantly, the review identified a trend of excluding marginalized demographics, raising concerns about the generalizability and external validity of findings. Conclusion: Our study underscores the necessity for future research to harmonize PNP methodologies, enhance transparency in collaborative efforts, and focus on addressing health inequalities to optimize the effectiveness of lung cancer navigation initiatives.
- Open Access
- 27 September 2025
- Published by Oxford University Press (OUP) in The Oncologist
- Vol. 30 (10)
The role of patient navigation programs in early cancer care in Mexico: a multi-case qualitative study
Background: In Mexico, academic publications on patient navigation are notably scarce. Thus, limited evidence in Mexico suggests that patient navigation programs (PNP) may play a promising role in early cancer care. The study’s aim is to identify and describe PNP in Mexico, particularly their role in early diagnosis and opportune treatment. Methods: Through an exploratory qualitative cross-sectional case study design. Five different programs were identified using snowball sampling. Thematic guides were developed. Data were collected through funnel-shaped semi-structured interviews with patient navigation providers. After familiarizing with the identified themes, codes were generated inductively. Results: PNP in Mexico navigate 1 or multiple types of cancer patients, using heterogeneous sources of funding, navigate 1 or multiple levels of healthcare and from within or outside of the healthcare system; they aim to improve access to healthcare, address barriers, and reduce wait times. However, PNP often engage in activities that are not aligned with their objectives. In assessing their impact, disparities are not measured, and no data are collected at time intervals. Conclusion: Using theoretical frameworks and logic models can support the implementation of new PNP, guide early diagnosis and treatment outcome measurement, and assess impact—ultimately helping ensure financial sustainability.
- 27 September 2025
- Published by Oxford University Press (OUP) in The Oncologist
- Vol. 30 (10)
Open AccessThe role of patient navigation programs in early cancer care in Mexico: a multi-case qualitative study
Background: In Mexico, academic publications on patient navigation are notably scarce. Thus, limited evidence in Mexico suggests that patient navigation programs (PNP) may play a promising role in early cancer care. The study’s aim is to identify and describe PNP in Mexico, particularly their role in early diagnosis and opportune treatment. Methods: Through an exploratory qualitative cross-sectional case study design. Five different programs were identified using snowball sampling. Thematic guides were developed. Data were collected through funnel-shaped semi-structured interviews with patient navigation providers. After familiarizing with the identified themes, codes were generated inductively. Results: PNP in Mexico navigate 1 or multiple types of cancer patients, using heterogeneous sources of funding, navigate 1 or multiple levels of healthcare and from within or outside of the healthcare system; they aim to improve access to healthcare, address barriers, and reduce wait times. However, PNP often engage in activities that are not aligned with their objectives. In assessing their impact, disparities are not measured, and no data are collected at time intervals. Conclusion: Using theoretical frameworks and logic models can support the implementation of new PNP, guide early diagnosis and treatment outcome measurement, and assess impact—ultimately helping ensure financial sustainability.
- Open Access
- 17 April 2025
- Published by Springer Nature in BMC Health Services Research
- Vol. 25 (1) , 1-13
Assessing disparities in cancer resources distribution in Mexico
Background: Given the rising cancer burden, the capacity of Mexico’s healthcare system to effectively address cancer care through its current available infrastructure becomes increasingly critical. Limited availability of diagnostic and therapeutic infrastructure leads to delays in diagnosis and treatment. Countries like Mexico, should undertake comprehensive assessments of infrastructure and human resources available for cancer, including its quantification and geolocation, to understand the service gaps. This study seeks to map oncological infrastructure in Mexico in five types of cancer: breast, lung, prostate, colon, and cervix. Methods: Through a realist evaluation of publicly available databases from the High Specialty Medical Equipment National Inventory and the General Direction of Health Information, a comprehensive identification and classification of cancer resources was conducted with the intended outcome to map cancer care infrastructure in Mexico. Guided by the literature, resources necessary for diagnosis and treatment were selected by an expert consensus. Thereafter, facilities were classified by service scope into either diagnostic or diagnostic and therapeutic, and by infrastructure level into core or enhanced and then mapped geographically. Results: From N = 14,133 unique healthcare facilities that deliver any type of healthcare, only 5% provided cancer care. Cancer-specific infrastructure that can provide diagnosis and treatment at the national level included N = 10 brachytherapy, N = 11 cobalt-60, N = 21 linear particle accelerators and N = 188 operating rooms. Five issues were found: (1) low availability of core therapeutic infrastructure across all cancer types; (2) regional and national centralization of available therapeutic infrastructure for all cancer types, whilst no centralization found in diagnostic resources; (3) inconsistent allocation of resources in densely populated areas; (4) infrastructure disparities per cancer type i.e., Lung, prostate, and breast cancer require significant investments in diagnostic infrastructure compared to cervical and colon cancer, and (5) lack of precise and updated infrastructure data from the public health system that requires either new codes or subcodes. Conclusions: Addressing disparities in cancer resources distribution in Mexico is a dual imperative—ensuring equity while seizing an opportunity to fortify the overall health system for people without social security coverage.
- 17 April 2025
- Published by Springer Nature in BMC Health Services Research
- Vol. 25 (1) , 1-13
Open AccessAssessing disparities in cancer resources distribution in Mexico
Background: Given the rising cancer burden, the capacity of Mexico’s healthcare system to effectively address cancer care through its current available infrastructure becomes increasingly critical. Limited availability of diagnostic and therapeutic infrastructure leads to delays in diagnosis and treatment. Countries like Mexico, should undertake comprehensive assessments of infrastructure and human resources available for cancer, including its quantification and geolocation, to understand the service gaps. This study seeks to map oncological infrastructure in Mexico in five types of cancer: breast, lung, prostate, colon, and cervix. Methods: Through a realist evaluation of publicly available databases from the High Specialty Medical Equipment National Inventory and the General Direction of Health Information, a comprehensive identification and classification of cancer resources was conducted with the intended outcome to map cancer care infrastructure in Mexico. Guided by the literature, resources necessary for diagnosis and treatment were selected by an expert consensus. Thereafter, facilities were classified by service scope into either diagnostic or diagnostic and therapeutic, and by infrastructure level into core or enhanced and then mapped geographically. Results: From N = 14,133 unique healthcare facilities that deliver any type of healthcare, only 5% provided cancer care. Cancer-specific infrastructure that can provide diagnosis and treatment at the national level included N = 10 brachytherapy, N = 11 cobalt-60, N = 21 linear particle accelerators and N = 188 operating rooms. Five issues were found: (1) low availability of core therapeutic infrastructure across all cancer types; (2) regional and national centralization of available therapeutic infrastructure for all cancer types, whilst no centralization found in diagnostic resources; (3) inconsistent allocation of resources in densely populated areas; (4) infrastructure disparities per cancer type i.e., Lung, prostate, and breast cancer require significant investments in diagnostic infrastructure compared to cervical and colon cancer, and (5) lack of precise and updated infrastructure data from the public health system that requires either new codes or subcodes. Conclusions: Addressing disparities in cancer resources distribution in Mexico is a dual imperative—ensuring equity while seizing an opportunity to fortify the overall health system for people without social security coverage.